Saba Capital Management, L.P. has demonstrated a clear buying bias in recent weeks, with 20 purchases compared to just five sales across its portfolio of 11 companies. The firm’s activity has largely centered on closed-end funds, including consistent purchases of NFJ Dividend, Interest & Premium Strategy Fund (NFJ), Mexico Fund (MXF), and New Germany Fund (GF). Between March 18 and March 27, 2026, Saba acquired over $3.2 million worth of NFJ shares in multiple transactions, with the largest single purchase exceeding $1.1 million on March 27. MXF saw steady buying as well, with purchases ranging from $22,064 on March 26 to $101,900 on March 18. Meanwhile, the firm has been trimming its position in BlackRock ESG Capital Allocation Term Trust (ECAT), selling $1.2 million worth of shares on March 27 alone and over $1.6 million earlier in the month.
Historically, Saba’s trading skews toward selling, with $818 million in total sell value dwarfing its $228 million in buys. However, the recent surge in purchases—particularly in NFJ, MXF, and GF—suggests a tactical shift. The firm’s buys have been methodical, often executed in smaller increments, while its sales, such as those in ECAT, have been more concentrated. This pattern aligns with Saba’s activist approach in closed-end funds, where it frequently pushes for discounts to narrow or shareholder-friendly policies. The transactions, disclosed in SEC Form 4 filings, reflect a disciplined, data-driven strategy rather than speculative positioning.
AI-assisted summary